• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢功能障碍与认知衰退及阿尔茨海默病的关联:代谢组学证据综述

Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence.

作者信息

Amidfar Meysam, Askari Gholamreza, Kim Yong-Ku

机构信息

Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110848. doi: 10.1016/j.pnpbp.2023.110848. Epub 2023 Aug 25.

DOI:10.1016/j.pnpbp.2023.110848
PMID:37634657
Abstract

The discovery of new biomarkers that can distinguish Alzheimer's disease (AD) from mild cognitive impairment (MCI) in the early stages will help to provide new diagnostic and therapeutic strategies and slow the transition from MCI to AD. Patients with AD may present with a concomitant metabolic disorder, such as diabetes, obesity, and dyslipidemia, as a risk factor for AD that may be involved in the onset of both AD pathology and cognitive impairment. Therefore, metabolite profiling, or metabolomics, can be very useful in diagnosing AD, developing new therapeutic targets, and evaluating both the course of treatment and the clinical course of the disease. In addition, studying the relationship between nutritional behavior and AD requires investigation of the role of conditions such as obesity, hypertension, dyslipidemia, and elevated glucose level. Based on this literature review, nutritional recommendations, including weight loss by reducing calorie and cholesterol intake and omega-3 fatty acid supplementation can prevent cognitive decline and dementia in the elderly. The underlying metabolic causes of the pathology and cognitive decline caused by AD and MCI are not well understood. In this review article, metabolomics biomarkers for diagnosis of AD and MCI and metabolic risk factors for cognitive decline in AD were evaluated.

摘要

发现能够在早期阶段将阿尔茨海默病(AD)与轻度认知障碍(MCI)区分开来的新生物标志物,将有助于提供新的诊断和治疗策略,并减缓从MCI向AD的转变。AD患者可能伴有代谢紊乱,如糖尿病、肥胖和血脂异常,这些作为AD的危险因素,可能参与AD病理和认知障碍的发病过程。因此,代谢物谱分析或代谢组学在诊断AD、开发新的治疗靶点以及评估治疗过程和疾病临床进程方面可能非常有用。此外,研究营养行为与AD之间的关系需要调查肥胖、高血压、血脂异常和血糖升高等情况所起的作用。基于这篇文献综述,包括通过减少热量和胆固醇摄入来减肥以及补充ω-3脂肪酸在内的营养建议,可以预防老年人的认知衰退和痴呆。AD和MCI所导致的病理和认知衰退的潜在代谢原因尚未完全明确。在这篇综述文章中,对用于诊断AD和MCI的代谢组学生物标志物以及AD中认知衰退的代谢危险因素进行了评估。

相似文献

1
Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence.代谢功能障碍与认知衰退及阿尔茨海默病的关联:代谢组学证据综述
Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110848. doi: 10.1016/j.pnpbp.2023.110848. Epub 2023 Aug 25.
2
Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.代谢综合征生物标志物与阿尔茨海默病轻中度认知障碍和痴呆阶段的认知衰退速度有关。
Alzheimers Res Ther. 2023 Mar 16;15(1):54. doi: 10.1186/s13195-023-01203-y.
3
4
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].[美国国立衰老研究所和阿尔茨海默病协会关于阿尔茨海默病诊断指南的2011年新建议:临床前阶段、轻度认知障碍和痴呆症]
Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.
5
Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.轻度认知障碍和轻度阿尔茨海默病中阿尔茨海默病评估量表-认知子量表变体:随时间的变化及强化策略的影响
Alzheimers Res Ther. 2016 Feb 12;8:8. doi: 10.1186/s13195-016-0170-5.
6
The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment.早期阿尔茨海默病患者与轻度认知障碍患者血清代谢物的差异
Front Neurol. 2019 Nov 22;10:1223. doi: 10.3389/fneur.2019.01223. eCollection 2019.
7
Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's Disease.发现一种代谢特征,使轻度认知障碍的高危患者易转化为阿尔茨海默病。
Int J Mol Sci. 2021 Oct 9;22(20):10903. doi: 10.3390/ijms222010903.
8
2022 Alzheimer's disease facts and figures.2022 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14.
9
Connected speech and language in mild cognitive impairment and Alzheimer's disease: A review of picture description tasks.轻度认知障碍和阿尔茨海默病中的连贯言语和语言:图片描述任务综述
J Clin Exp Neuropsychol. 2018 Nov;40(9):917-939. doi: 10.1080/13803395.2018.1446513. Epub 2018 Apr 19.
10
Verification of the association between cognitive decline and olfactory dysfunction using a DEmentia screening kit in subjects with Alzheimer's dementia, mild cognitive impairment, and normal cognitive function (DESK study): A multicenter, open-label, interventional study.使用痴呆筛查试剂盒在阿尔茨海默病痴呆、轻度认知障碍和认知功能正常的受试者中验证认知衰退与嗅觉功能障碍之间的关联(DESK研究):一项多中心、开放标签的干预性研究。
eNeurologicalSci. 2022 Dec 1;29:100439. doi: 10.1016/j.ensci.2022.100439. eCollection 2022 Dec.

引用本文的文献

1
Metabolic dysregulation in Alzheimer's disease: A brain metabolomics approach.阿尔茨海默病中的代谢失调:一种脑代谢组学方法。
Alzheimers Dement. 2025 Sep;21(9):e70528. doi: 10.1002/alz.70528.
2
Spatiotemporal transcriptomic profiling reveals metabolic dysfunction prior to overt tauopathy in the PS19 mouse model.时空转录组分析揭示了PS19小鼠模型中tau蛋白病明显出现之前的代谢功能障碍。
Res Sq. 2025 Jul 10:rs.3.rs-6941464. doi: 10.21203/rs.3.rs-6941464/v1.
3
Linking Metabolic Syndrome to Neurodegeneration Mechanisms and Potential Treatments.
将代谢综合征与神经退行性变机制及潜在治疗方法相联系
Mol Neurobiol. 2025 Apr 24. doi: 10.1007/s12035-025-04947-w.
4
FTO inhibition mitigates high-fat diet-induced metabolic disturbances and cognitive decline in SAMP8 mice.FTO抑制减轻了高脂饮食诱导的SAMP8小鼠的代谢紊乱和认知衰退。
Mol Med. 2025 Feb 21;31(1):73. doi: 10.1186/s10020-025-01126-4.
5
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization.用于生物标志物分类的常见阿尔茨海默病研究本体(CADRO)。
Alzheimers Dement (N Y). 2025 Feb 11;11(1):e70050. doi: 10.1002/trc2.70050. eCollection 2025 Jan-Mar.
6
Protective signature of xanthohumol on cognitive function of APP/PS1 mice: a urine metabolomics approach by age.黄腐酚对APP/PS1小鼠认知功能的保护作用:基于年龄的尿液代谢组学方法
Front Pharmacol. 2024 Jul 24;15:1423060. doi: 10.3389/fphar.2024.1423060. eCollection 2024.
7
Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis.糖尿病在轻度认知障碍诊断后的第一年加速了阿尔茨海默病的进展。
Alzheimers Dement. 2024 Jul;20(7):4583-4593. doi: 10.1002/alz.13882. Epub 2024 Jun 12.
8
Assessing the Biological Mechanisms Linking Smoking Behavior and Cognitive Function: A Mediation Analysis of Untargeted Metabolomics.评估吸烟行为与认知功能之间的生物学机制:非靶向代谢组学的中介分析
Metabolites. 2023 Nov 16;13(11):1154. doi: 10.3390/metabo13111154.